T CELL-INDUCING VACCINE CONTAINING INTEREPITOPE SEQUENCE PROMOTING ANTIGEN PRESENTATION
    4.
    发明公开
    T CELL-INDUCING VACCINE CONTAINING INTEREPITOPE SEQUENCE PROMOTING ANTIGEN PRESENTATION 审中-公开
    T-ZELLEN-INDUZIERENDER IMPFSTOFF MIT INTEREPITOP-SEQUENZ-FÖRDERNDERANTIGENDARSTELLUNG

    公开(公告)号:EP3053592A1

    公开(公告)日:2016-08-10

    申请号:EP14850811.2

    申请日:2014-10-01

    摘要: The purpose of the present invention is to provide an interepitope sequence that effectively induces antigen presentation of each epitopes in a long-chain peptide antigen having a plurality of epitopes. A vaccine for the purpose contains a long-chain peptide antigen having a plurality of epitopes, said vaccine being characterized in that a sequence between the individual epitopes is one sequence selected from the group consisting of two to ten consecutive tyrosines, two to ten consecutive threonines, two to ten consecutive alanines, two to ten consecutive histidines, two to ten consecutive glutamines and two to ten consecutive asparagines. It is preferred that the vaccine is one selected from the group consisting of an anticancer vaccine, an antibacterial vaccine and an antiviral vaccine. It is also preferred that the vaccine is at least one selected from the group consisting of a peptide vaccine, a DNA vaccine, an mRNA vaccine and a dendritic cell vaccine.

    摘要翻译: 本发明的目的是提供一种有效地诱导具有多个表位的长链肽抗原中每个表位的抗原呈递的相互联系的序列。 用于该目的的疫苗包含具有多个表位的长链肽抗原,所述疫苗的特征在于,各个表位之间的序列是选自二至十个连续酪氨酸,二至十个连续苏氨酸的一个序列 连续两至十次丙烯腈,连续二至十次组氨酸,连续二至十次戊二胺,连续两至十次天冬酰胺。 疫苗优选为选自抗癌疫苗,抗菌疫苗和抗病毒疫苗的疫苗。 还优选疫苗是选自肽疫苗,DNA疫苗,mRNA疫苗和树突状细胞疫苗中的至少一种。